Advertisement
Persons > All
Find below all kinds of persons.Total search results: 8918 | Ordered by Country (ascending)
1 2 3 ... 73 74 75 ... 88 89 90
Person | Position | Organisation (Group) | Country |
---|---|---|---|
Foster, Jason C. (Oribiotech 202001– CEO) | Chief Executive Officer (CEO) | Ori Biotech (Oribiotech) (Group) | United Kingdom (GB) |
Foulger, Paul (EKF Diagnostics 201307– Interim Finance Director before Company Secretary) | Chief Financial Officer (CFO) | EKF Diagnostics (Group) | United Kingdom (GB) |
Fowles, Richard (United Kingdom (govt) 201010 Category Manager at RCUK SSC Ltd) | n. a. | United Kingdom (GB) (govt) | United Kingdom (GB) |
Fraser, Paul D. (Univ London 201403 Professor at Royal Holloway and Bedford New College) | Professor | University of London | United Kingdom (GB) |
Friedrich, Eva (SDL 201604 Field Marketing Manager DACH) | n. a. | SDL (Group) | United Kingdom (GB) |
Friedrich, Glenn A. (Kymab 201511 COO) | Chief Operating Officer (COO) | Sanofi (Group) [since May 2011] | United Kingdom (GB) |
Fulton, Gemma (BioOutsource 201406 Sales + Marketing Associate) | Sales Manager / Marketing Manager | Sartorius (Group) | United Kingdom (GB) |
Gadsby, Martin (Optimal Industrial 202204 CEO + Co-Founder) | Chief Executive Officer (CEO) | Bruker (Group) | United Kingdom (GB) |
Galbraith, Daniel (BioOutsource 201402 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Sartorius (Group) | United Kingdom (GB) |
Galbraith, Susan (AstraZeneca 201212 VP + Head Oncology Innovative Medicines Unit) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | United Kingdom (GB) |
Gales, Ann (A Gales Consulting 201709 Managing Partner) | Managing Partner | A Gales Consulting Ltd. | United Kingdom (GB) |
Gallagher, Stephen (Steve) (Dotmatics 200612 CEO) | Chief Executive Officer (CEO) | Insightful Science (Group) | United Kingdom (GB) |
Gardner, Chris (Consilium 201507– Partner before since 2003 at Citigate Dewe Rogerson London) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
Garnier, Jean-Pierre (Pierre Fabre Labs 2008–2010 CEO before GSK 2001–2008 CEO before SmithKline Beecham CEO) | Chief Executive Officer (CEO) | GSK (Group) | United Kingdom (GB) |
George, Peter (Clinigen Group 201303 CEO) | Chief Executive Officer (CEO) | Clinigen (Group) | United Kingdom (GB) |
Gibson-Brade, Emma (Peak Scientific 201304– Market Researcher) | market research | Peak Scientific (Group) | United Kingdom (GB) |
Gilham, Ian D. (Axis-Shield 200801 CEO– before COO) | Chief Executive Officer (CEO) | Abbott (Group) | United Kingdom (GB) |
Gladsden, Brian (Mosaic Therapeutics 202304– CEO before Novartis + Bayer) | Chief Executive Officer (CEO) | Mosaic Therapeutics Ltd. | United Kingdom (GB) |
Glass, Steve (BioMarin Europe 200801– VP + General Manager before Altana) | Managing Director | BioMarin (Group) | United Kingdom (GB) |
Goldman, Jonathan (Abzena 202201 CEO formerly Aptuit CEO) | Chief Executive Officer (CEO) | Abzena (Group) | United Kingdom (GB) |
Goldsmith, George (Compass Pathways 202004 CEO + Co-Founder) | Chief Executive Officer (CEO) | Compass Pathways (Group) | United Kingdom (GB) |
Gooch, Daniel (Scius Communciations 202109 formerly Instinctif Partners 201509) | Public Relations Manager / Investor Relations Manager | Scius Communications (GB) | United Kingdom (GB) |
Grabulovski, Dragan (Bellevue 202109– Venture Partner at Pureos Bioventures before Covagen CSO + co-founder) | Partner (venture partner) | Bellevue (Group) | United Kingdom (GB) |
Grainger, David (Medixci Ventures 201602– General Partner before Index Ventures 2012– + Funxional Therapeutics) | General Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | United Kingdom (GB) |
Green, Nicholas (Coulter Partners 201711 Managing Partner) | Managing Partner | Coulter Partners (The Coulter Partnership Ltd.) | United Kingdom (GB) |
Green, Nicola (Halesway Ltd 201201– Account Director before Alto Marketing 201110 Account Director, Life Science) | public relations / investor relations | Halesway Ltd. | United Kingdom (GB) |
Griffin, Conor (Hume Brophy 201802 Managing Director International Healthcare) | Managing Director | Hume Brophy Communications | United Kingdom (GB) |
Griffiths, David (LGC 201704 Managing Director of LGC LMS division) | Managing Director | LGC (Group) | United Kingdom (GB) |
Günther, Rolf H. (Bicycle Therapeutics 201204– CEO before Affimed 2004– CEO + COO before Aventis Behring) | Chief Executive Officer (CEO) | Bicycle Therapeutics (Group) | United Kingdom (GB) |
Haas, Eva (Optimum Strategic Communications 201710– before Hume Brophy) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | United Kingdom (GB) |
Haigh, Robert (Macomics 202007– CEO + Executive Chair of Ikarovec before Ferring + Boehringer Ingelheim) | Chief Executive Officer (CEO) | Macomics Ltd. | United Kingdom (GB) |
Hall, Bridget (Fujifilm 201310 Communications Manager at Fujifilm Diosynth Biotechnologies UK Ltd) | Public Relations Manager / Investor Relations Manager | Fujifilm (Group) | United Kingdom (GB) |
Hall, Matthew (Oncimmune 201906 CFO + 201904– Managing Director at Oncimmune Germany GmbH) | Chief Financial Officer (CFO) | Freenome (Group) | United Kingdom (GB) |
Hallett, David (Exscientia 202001–COO before Evotec + Merck & Co) | Chief Operating Officer (COO) | Exscientia (Group) | United Kingdom (GB) |
Hamacher, Christiane (Biocon 201910 CEO of Biocon Biologics) | Chief Executive Officer (CEO) | Biocon (Group) | United Kingdom (GB) |
Hammond, Matt (Foresight Group 202205 Partner) | Partner (venture partner) | Foresight Group (Group) | United Kingdom (GB) |
Hannah, David (Link Technologies 201409 Head of Marketing) | Sales Manager / Marketing Manager | Link Technologies Ltd. | United Kingdom (GB) |
Hardy, David (ACD/Labs 201404 MS Product Manager before Waters UK + Shimadzu UK) | Product Manager (personnel) | Advanced Chemistry Development (ACD/Labs) (Group) | United Kingdom (GB) |
Harold, Theodora (Crescendo Biologics 201905– CEO before CFO before PsiOxus + Mission Tx + OrthoMimectics + Cytomax) | Chief Executive Officer (CEO) | Crescendo Biologics Ltd. | United Kingdom (GB) |
Harrison, Tim (Almac 201506 VP Drug Discovery at Almac Discovery) | Research & Development Manager | Almac (Group) | United Kingdom (GB) |
Harvey, Lucy (QuantuMDx 201506 Business Development + Marketing Officer) | Business Development Manager / Strategy Manager | QuantuMDx (Group) | United Kingdom (GB) |
Hasan, Rafiq (Complement Therapeutics 202202– CEO before Exact Therapeutics + Bayer + Novartis) | Chief Executive Officer (CEO) | Complement Therapeutics (CTx) (Group) | United Kingdom (GB) |
Hassabis, Demis (Alphabet 202107 CEO + Co-Founder of DeepMind) | Chief Executive Officer (CEO) | Alphabet (formerly Google) (Group) | United Kingdom (GB) |
Haurum, John (F-Star 201205–201810 CEO before ImClone System + Symphogen LEFT 10/18) | Chief Executive Officer (CEO) | Sino Biopharm (Group) | United Kingdom (GB) |
Hawkins, Tim (Schauenburg 201308– Finance Director at Markes Intl before PriceWaterhouseCoopers) | Chief Financial Officer (CFO) | Schauenburg (Group) | United Kingdom (GB) |
Healey, Joseph R.J. (Joe) (NanoSyrinx 202012 CEO + Co-Founder) | Chief Executive Officer (CEO) | NanoSyrinx Ltd. | United Kingdom (GB) |
Heggie, Theresa (Freeline Therapeutics 202006– CEO before Alnylam + Shire + Jerini + Baxter + Janssen) | Chief Executive Officer (CEO) | Freeline Therapeutics (Group) | United Kingdom (GB) |
Hepburne-Scott, Charlotte (Optimum Strategic Communications 202104) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | United Kingdom (GB) |
Herrmann, Max (Silence Therapeutics 201108 CFO + acting CEO beforre Intercytex 200809– CFO) | Chief Financial Officer (CFO) | Silence Therapeutics (Group) | United Kingdom (GB) |
Herschel, Candice (LifeScience Connect 202309 Head of Community) | n. a. | LifeScience Connect Ltd. (LifeScience ORG) | United Kingdom (GB) |
Herzog, Christian (Holtzbrinck 202306 Chief Product Officer at Digital Science + Co-Founder of Dimensions) | Product Manager (personnel) | Holtzbrinck (Group) | United Kingdom (GB) |
Heukamp, Wessel (Freshfields Bruckhaus Deringer 201610) | Attorney / Lawyer | Freshfields (Group) | United Kingdom (GB) |
Hill, Adam M. (Oncimmune 201810– CEO joined 201803 before McLaren Applied Technologies) | Chief Executive Officer (CEO) | Freenome (Group) | United Kingdom (GB) |
Hill, Adrian (Univ Oxford 201506 Professor + Director of Jenner Institute) | Professor | University of Oxford | United Kingdom (GB) |
Hirsch, Volker (United Kingdom (govt) 202210– CCO at Medicines Discovery Catapult before Amadeus Capital) | Chief Commercial Officer (CCO) | United Kingdom (GB) (govt) | United Kingdom (GB) |
Hirst, Simon (Sygnature Discovery 201112 CEO + Founder) | Chief Executive Officer (CEO) | Sygnature Discovery (Group) | United Kingdom (GB) |
Hockley, Christine (United Kingdom (govt) 202402 Managing Director for Funds at British Patient Capital) | Managing Director | United Kingdom (GB) (govt) | United Kingdom (GB) |
Hogan, Simon (HydrogenOne 202205 Chairman) | Board member (all kinds of boards: supervisory, advisory, management etc.) | Foresight Group (Group) | United Kingdom (GB) |
Hohm, Tim (Optibrium 202002– Director of Commercial Strategy and Business Development before Novo Nordisk) | Business Development Manager / Strategy Manager | Optibrium (Group) | United Kingdom (GB) |
Holland, Richard (Eagle Genomics 201201 CBO + Co-founder) | Chief Business Officer (CBO) | Eagle Genomics Ltd. | United Kingdom (GB) |
Holloway, Sakura (Start Codon 201907– Partner + Head of Diligence before Merck KGaA + OneVentures Pty Ltd + Benitec) | Partner (venture partner) | Start Codon Ltd. | United Kingdom (GB) |
Hoogenboom, Bart (Univ College London 201909 Prof of Biophysics at London Centre for Nanotechnology) | Professor | University College London (UCL) | United Kingdom (GB) |
Hopkins, Andrew (Ex Scientia 201604 CEO) | Chief Executive Officer (CEO) | Exscientia (Group) | United Kingdom (GB) |
Horgan (Nguyen), Anne (Viet-Anh) (Cambridge Innovation Capital 202304 Partner) | Partner (venture partner) | Cambridge Innovation Capital (Group) | United Kingdom (GB) |
Humphrys, Emily (Cambridge Research Biochemicals 202305 Managing Director) | Managing Director | Biosynth (since 9/22) (Group) | United Kingdom (GB) |
Ibrahim, Adrian (Wellcome Trust 202101 Head of Technology Transfer + Business Development at Sanger Institute) | IP Manager | Wellcome Trust, The | United Kingdom (GB) |
Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc) | Chief Executive Officer (CEO) | Autolus Therapeutics plc (Nasdaq: AUTL) | United Kingdom (GB) |
Jackson, Oliver (Peel Hunt 201707) | n. a. | Peel Hunt LLP | United Kingdom (GB) |
Jallal, Bahija (Immunocore 201901– CEO before AstraZeneca President MedImmune joined MedImmune 2006) | Chief Executive Officer (CEO) | Immunocore (Group) | United Kingdom (GB) |
James, Alison (Coulter Partners 201712 Director PR + Marketing) | Public Relations Manager / Investor Relations Manager | Coulter Partners (The Coulter Partnership Ltd.) | United Kingdom (GB) |
Jeffreys, Hayden (Lumora 2013– Commercial Director) | Chief Commercial Officer (CCO) | Erba Diagnostics Mannheim (Group) | United Kingdom (GB) |
Jenkins, Richard (Silence Therapeutics 201806– Head of Clinical Development before Takeda + GSK + Roche) | Chief Medical Officer (CMO) | Silence Therapeutics (Group) | United Kingdom (GB) |
John, Llewellyn (Nova Capital 200601 Accociated Partners before Deloitte) | n. a. | Nova Capital (Group) | United Kingdom (GB) |
Johnson, Kevin Stuart (Medicxi Ventures 201602– General Partner before Index Ventures + PanGenetics + CAT) | General Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | United Kingdom (GB) |
Jung, Christian Billy (Dementia Discovery Fund 202106 Partner formerly HTGF 201305 Investment Manager) | Board member, executive | SV Health Investors (Group) | United Kingdom (GB) |
Kang, Rajin (BenevolentAI 202309 VP Communications) | Public Relations Manager / Investor Relations Manager | BenevolentAI (Group) | United Kingdom (GB) |
Karlsson, Jan-Anders (Verona Pharma 201403 CEO) | Chief Executive Officer (CEO) | Verona Pharma (Group) | United Kingdom (GB) |
Kawaletz, Gregor (Albumedix 202006– CCO before IDT Biologika + Next Pharma + Catalent Pharma Solutions) | Chief Commercial Officer (CCO) | Sartorius (Group) | United Kingdom (GB) |
Kay, Andrew (NuCana 202012– Board Chairman also at Boards of NeRRe Tx + Blueberry Tx former CEO of Algeta) | Board member, non-executive | NuCana plc (Nasdaq: NCNA) | United Kingdom (GB) |
Keen, Nicholas (Bicycle Therapeutics 201701– CSO before Novartis + AstraZeneca) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bicycle Therapeutics (Group) | United Kingdom (GB) |
Kerouedan, Christelle (Coulter Partners 202109– Marketing Director before Instinctif Partners) | Sales Manager / Marketing Manager | Coulter Partners (The Coulter Partnership Ltd.) | United Kingdom (GB) |
Kerr, Mary (Nerre Therapeutics 201510– CEO before GSK + Advent Life Sciences) | Chief Executive Officer (CEO) | Nerre Therapeutics Ltd. | United Kingdom (GB) |
Kerr, Paul (Fusion Antibodies 201205 Managing Director) | Managing Director | Fusion Antibodies (Group) | United Kingdom (GB) |
Kirby, Julian (Bico 202207 Business Development Manager at Scienion UK) | Business Development Manager / Strategy Manager | Bico (Group) | United Kingdom (GB) |
Koehn, Jadranka (Rentschler 202011 Senior Direct Innovation Partnerships) | Business Development Manager / Strategy Manager | Rentschler (Group) | United Kingdom (GB) |
Kramer, Ann (Oxitec 200610 Head Business Development) | Business Development Manager / Strategy Manager | Third Security (Randal J. Kirk) (Group) | United Kingdom (GB) |
Krickl, Reinhard (Phagenesis 201609 CEO) | Chief Executive Officer (CEO) | Nestlé (Group) | United Kingdom (GB) |
Kruize, Niels (LGC 201108 Sales Director LGC Genomics) | Sales Manager / Marketing Manager | LGC (Group) | United Kingdom (GB) |
Kusser, Wolfgang (Automation Partnership 201102– Sales Manager DE+AT+CH before Invitrogen Germany) | Sales Manager / Marketing Manager | Sartorius (Group) | United Kingdom (GB) |
Kuzmin, Dmitry (Dima) (4BIO Ventures 2019 Managing Partner) | Managing Partner (investment firm) | 4BIO Ventures (4BIO Capital) (Group) | United Kingdom (GB) |
Lancaster, Madeline (MRC LMB 201908 Principal Researcher + Co-Founder of a:head bio) | Researcher (university / research institute) | United Kingdom (GB) (govt) | United Kingdom (GB) |
Lanckriet, Heikki (Expedeon 201111 CEO + Founder) | Chief Executive Officer (CEO) | 2invest (Group) | United Kingdom (GB) |
Lavino, Francesco Maria (F2G 202104– CEO before Nabriva Therapeutics + Merck (US) + Cubist Pharmaceuticals) | Chief Executive Officer (CEO) | F2G (Group) | United Kingdom (GB) |
Law, Richard (Exscientia 202101– EVP Strategic Alliances before Evotec + UCSD + LLNL) | Business Development Manager / Strategy Manager | Exscientia (Group) | United Kingdom (GB) |
Lawson, Jennifer (Sartorius 201901 Product Manager for Testing at Sartorius Stedim BioOutsource) | Product Manager (personnel) | Sartorius (Group) | United Kingdom (GB) |
Lawton, Vincent (Merck (US) former Managing Director of Merck Sharp & Dohme UK + VP MSD Europe) | Managing Director | Merck (US) (MSD) (Group) | United Kingdom (GB) |
Lernbecher, Thomas (4titude Ltd 201710 Co-Founder) | Company Founder | Azenta (Group) | United Kingdom (GB) |
Leslie, Carol (Andrew Lloyd & Associates 201509) | public relations / investor relations | Andrew Lloyd & Associates (ALA) | United Kingdom (GB) |
Leyendecker, Ludwig (Freshfields Bruckhaus Deringer 201610) | Attorney / Lawyer | Freshfields (Group) | United Kingdom (GB) |
Ligner, Emmanuel (General Electric 201812 President + CEO GE Healthcare Life Sciences) | Chief Executive Officer (CEO) | General Electric (Group) | United Kingdom (GB) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top